The International Headache Academy is designed to inspire a long-term commitment to headache medicine in young neurologists and research scientists via an educational program focused on clinical and research aspects of the field.

The American Headache Society is dedicated to mentoring future leaders in headache medicine through both outreach and continued education.

PROGRAM DETAILS

The Tenth Annual IHA will be held January 25-27, 2024 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.

Participants will be introduced to multiple opportunities in the field of Headache Medicine, with the world’s leading experts providing hands-on instruction in the pathophysiology, diagnosis, treatment, and education of patients with migraine, cluster headache, and related primary headache disorders, as well as practical education in clinical trial methodology, biostatistics, and the preparation and publication of study results.

The program features formal conference sessions as well as networking opportunities to meet colleagues and headache medicine experts. Small research grants may also be available through submission of an optional research proposal.

HEALTH AND SAFETY POLICY

The AHS actively monitors the health and safety guidance from the Centers for Disease Control as well as state and local health departments. We want attendees to enjoy a safe environment at all AHS meetings. While the AHS continues to recommend people are up to date on COVID-19 vaccination, attendees of AHS meetings are not required to be vaccinated or verify vaccination status. In addition, masks are optional for AHS meetings and prior antigen testing is not required. We will continue to follow best practices recommended by the Centers for Disease Control and Prevention and abide by any legal mandates and recommendations from government officials in the location of any AHS meeting. These protocols and information are subject to change.

Please note, even with safeguards and the AHS’s overarching commitment to attendee wellness, there remains a risk of contracting COVID-19.

IHA Planning and Research Committee Co-Chairs

Elizabeth Leroux, MD Clinique de la Migraine Montreal, Quebec

William Renthal, MD, PhD, FAHS Brigham and Women’s Hospital/Harvard Medical School Boston, Massachusetts

PURPOSE/OBJECTIVE

At the conclusion of the program, participants will report that they intend to change practice as it relates to the management of patients presenting with primary and secondary head pain, migraine, cluster headache, and related primary headache conditions, will be proficient in the development of evidence-based treatment plans involving medications/devices, complementary and alternative medicine and/or behavioral techniques, remember the steps involved in conducting a clinical trial and preparing the findings for publication, and will be able to effectively communicate with headache patients and caregivers, both in eliciting information for history taking and providing information for education.

ACCREDITATION STATEMENT

The American Headache Society^® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society^® designates this Live activity for a maximum of 10.00 AMA PRA Category 1 Credits^™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME

• Complete the post-activity evaluation here. Please create a visitor account and be sure to use the email address you applied with.
• Enter the number of CME credits being claimed.
• Download your certificate.

Please note: The maximum number of credits is calculated based on attending all live sessions.

DISCLOSURE STATEMENT AND DISCLOSURES

The planners and faculty for this activity have no relevant relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society gratefully acknowledges the educational grants received for the International Headache Academy from our Industry Supporters:

AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Pfizer Inc.

2024 International Headache Academy Program Agenda

January 25 – 27, 2024

UCLA Meyer and Renee Luskin Conference Center, Los Angeles, CA

Program Chairs: Elizabeth Leroux, MD, FRCPC and William Renthal, MD, PhD, FAHS

Candidate Criteria
Interested applicants must be a PGY 3+ Resident, headache medicine fellow, or MD and/or PhD clinician/researcher currently enrolled or within 5 years of having completed their training in the US, Canada, or Latin America. Previous participants of IHA are encouraged to apply should they meet eligibility requirements as outlined.

Application and Supporting Materials
Applicants must complete an online application form and provide the following supporting materials:

• CV
• Brief academic update (presentations delivered, abstracts published, manuscripts published or in press, book chapters published or in press, academic promotion, academic appointments, projects funded, or any other update)
• Letter of support from Department Chair, Program Director, or AHS member
• A demonstrated interest in headache medicine
• Completion of statement of interest and financial disclosure form

Applications will be reviewed and rated according to the following:

• Academic history and productivity
• Field of study
• Place of study
• Quality of research to date (if any)
• Potential for the applicant to provide leadership in headache medicine and make meaningful contributions to headache research and/or clinical care for many years

Accepted applicants will receive:

Through submission of an optional research proposal, selected applicants may be eligible to receive a $10,000 grant to fund their research project, and those selected will be invited to present at the 67th Annual Scientific Meeting in 2025.

Accepted applicants will also receive a stipend up to $1,500 toward eligible travel expenses and a one-year AHS Trainee membership or a extension of their existing Trainee membership.

Application Timeline:

• Wednesday, August 30: Applications open
• Monday, October 2: Applications due
• On or about Monday, October 16: Final decisions to be distributed

The American Headache Society gratefully acknowledges the educational grant support of the 2024 International Headache Academy from our industry supporters:

AbbVie Inc.
Amgen Inc.
Eli Lilly and Company
Pfizer, Inc.